标题
The Cost of Relapse in Schizophrenia
作者
关键词
-
出版物
PHARMACOECONOMICS
Volume 35, Issue 9, Pages 921-936
出版商
Springer Nature
发表日期
2017-05-22
DOI
10.1007/s40273-017-0515-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Comparative cost-effectiveness of 11 oral antipsychotics for relapse prevention in schizophrenia within Singapore using effectiveness estimates from a network meta-analysis
- (2016) Liang Lin et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Impact of Paliperidone Palmitate Versus Oral Atypical Antipsychotics on Health Care Resource Use and Costs in Veterans with Schizophrenia
- (2016) Yinong Young-Xu et al. JOURNAL OF CLINICAL PSYCHIATRY
- The Economic Burden of Schizophrenia in the United States in 2013
- (2016) Martin Cloutier et al. JOURNAL OF CLINICAL PSYCHIATRY
- 6.97 INPATIENT BURDEN OF CHILDHOOD SCHIZOPHRENIA IN THE UNITED STATES
- (2016) Raghu Gandhi et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- The Societal Cost of Schizophrenia: A Systematic Review
- (2016) Huajie Jin et al. PHARMACOECONOMICS
- Hospitalized Patients with Schizophrenia In Portugal: Clinical Characterization and Costs
- (2016) R Ascenção et al. VALUE IN HEALTH
- Health care resource utilization and direct medical costs for patients with schizophrenia initiating treatment with atypical versus typical antipsychotics in Tianjin, China
- (2015) Xiaoning He et al. BMC HEALTH SERVICES RESEARCH
- Cost-Effectiveness of Financial Incentives to Promote Adherence to Depot Antipsychotic Medication: Economic Evaluation of a Cluster-Randomised Controlled Trial
- (2015) Catherine Henderson et al. PLoS One
- Prevalence, Employment Rate, and Cost of Schizophrenia in a High-Income Welfare Society: A Population-Based Study Using Comprehensive Health and Welfare Registers
- (2015) Stig Evensen et al. SCHIZOPHRENIA BULLETIN
- Medication use patterns, Health-care resource Utilization and Economic burden for patients with Schizophrenia in Beijing, China
- (2015) Y. Chen et al. VALUE IN HEALTH
- Health resource and Criminal Justice system costs for Young Clinical Trial Patients with Schizophrenia and prior Incareration by treatment failure status
- (2015) C. Kozma et al. VALUE IN HEALTH
- Healthcare utilization and costs of veterans health administration patients with schizophrenia treated with paliperidone palmitate long-acting injection or oral atypical antipsychotics
- (2015) Onur Baser et al. JOURNAL OF MEDICAL ECONOMICS
- Economic Grand Rounds: Treatment Participation and Medication Adherence: Effects on Criminal Justice Costs of Persons With Mental Illness
- (2014) Allison G. Robertson et al. PSYCHIATRIC SERVICES
- Impact of Early Nonadherence to Oral Antipsychotics on Clinical and Economic Outcomes Among Patients with Schizophrenia
- (2013) Steve Offord et al. ADVANCES IN THERAPY
- Pharmacoeconomics of depot antipsychotics for treating chronic schizophrenia in Sweden
- (2013) Thomas R. Einarson et al. NORDIC JOURNAL OF PSYCHIATRY
- Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review
- (2013) José M Olivares et al. Annals of General Psychiatry
- Impact on healthcare resource usage and costs among Medicaid-insured schizophrenia patients after initiation of treatment with long-acting injectable antipsychotics
- (2013) Rimal Bera et al. JOURNAL OF MEDICAL ECONOMICS
- Patterns of relapse and associated cost burden in schizophrenia patients receiving atypical antipsychotics
- (2013) Marie-Hélène Lafeuille et al. JOURNAL OF MEDICAL ECONOMICS
- Effectiveness of the Information Technology-Aided Program of Relapse Prevention in Schizophrenia (ITAREPS)
- (2012) FILIP ŠPANIEL et al. Journal of Psychiatric Practice
- A cost-consequence analysis of long-acting injectable risperidone in schizophrenia: A one-year mirror-image study with national claim-based database in Taiwan
- (2012) Hui-Chih Chang et al. JOURNAL OF PSYCHIATRIC RESEARCH
- An Examination of Costs, Charges, and Payments for Inpatient Psychiatric Treatment in Community Hospitals
- (2012) Michael Stensland et al. PSYCHIATRIC SERVICES
- Cost effectiveness of paliperidone palmitate versus risperidone long-acting injectable and olanzapine pamoate for the treatment of patients with schizophrenia in Sweden
- (2012) Angelika Mehnert et al. JOURNAL OF MEDICAL ECONOMICS
- A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia in Sweden
- (2011) Eva Lindström et al. NORDIC JOURNAL OF PSYCHIATRY
- PMH27 INPATIENT COST OF SCHIZOPHRENIA TREATMENT IN TURKEY
- (2011) A Ayer et al. VALUE IN HEALTH
- PMH30 HOSPITALIZATION COSTS FOR SCHIZOPHRENIA RELAPSES IN A PUBLIC PSYCHIATRIC INSTITUTION
- (2011) W Verduzco et al. VALUE IN HEALTH
- PMH20 IMPACT AND COSTS OF HOSPITALIZATION IN SCHIZOPHRENIA
- (2011) J Zeidler et al. VALUE IN HEALTH
- PMH19 Cost of Relapse in Schizophrenia in Europe: The Constatre Study
- (2011) M. Hemels et al. VALUE IN HEALTH
- PMH29 ESTIMATION OF DIRECT COSTS OF TREATING SCHIZOPHRENIA FOR COMMUNITY-DWELLING UNITED STATES RESIDENTS
- (2011) P. Desai et al. VALUE IN HEALTH
- Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia
- (2010) Haya Ascher-Svanum et al. BMC Psychiatry
- The cost of relapse and the predictors of relapse in the treatment of schizophrenia
- (2010) Haya Ascher-Svanum et al. BMC Psychiatry
- Comparative Effectiveness of Long-Acting Risperidone in New Zealand
- (2010) Christopher Carswell et al. CLINICAL DRUG INVESTIGATION
- Burden of schizophrenia in recently diagnosed patients: healthcare utilisation and cost perspective
- (2010) Deborah Nicholl et al. CURRENT MEDICAL RESEARCH AND OPINION
- Direct medical costs associated with schizophrenia relapses in health care services in the city of São Paulo
- (2010) Claudiane Salles Daltio et al. REVISTA DE SAUDE PUBLICA
- The Cost of Relapse in Schizophrenia and Schizoaffective Disorder
- (2009) Paul Fitzgerald et al. Australasian Psychiatry
- Direct medical mental health care costs of schizophrenia in France, Germany and the United Kingdom – Findings from the European Schizophrenia Cohort (EuroSC)
- (2009) Dirk Heider et al. EUROPEAN PSYCHIATRY
- Long-term observation of patients successfully switched to risperidone long-acting injectable: A retrospective, naturalistic 18-month mirror-image study of hospitalization rates and therapy costs
- (2009) Birgit Spill et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- The cost of relapse in patients with schizophrenia in the European SOHO (Schizophrenia Outpatient Health Outcomes) study
- (2009) Jihyung Hong et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cost-effectiveness of atypical antipsychotics for the management of schizophrenia in the UK
- (2008) Andrew Davies et al. CURRENT MEDICAL RESEARCH AND OPINION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More